Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jaktinib in severe alopecia areata
NCT05051761Phase 3Completed
- Sponsor
- Zelgen
- Start
- Sep 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of jaktinib in alopecia areata, sponsored by Zelgen. Started Sep 2021; status: completed.
02
Drugs
jaktinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT05051761.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05051761.